These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 24780598)

  • 1. Synthesis, antidiabetic activity and molecular docking studies of novel aryl benzylidenethiazolidine-2,4-dione based 1,2,3-triazoles.
    Patnam N; Chevula K; Chennamsetti P; Aleti B; Kotha AK; Manga V
    Mol Divers; 2024 Jun; 28(3):1551-1563. PubMed ID: 37326778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of new piplartine analogues as potent aldose reductase inhibitors (ARIs).
    Rao VR; Muthenna P; Shankaraiah G; Akileshwari C; Babu KH; Suresh G; Babu KS; Chandra Kumar RS; Prasad KR; Yadav PA; Petrash JM; Reddy GB; Rao JM
    Eur J Med Chem; 2012 Nov; 57():344-61. PubMed ID: 23124161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 2-phenoxypyrido[3,2-
    Hao X; Qi G; Ma H; Zhu C; Han Z
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1368-1372. PubMed ID: 31347930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse Pharmacological Potential of different Substituted Pyrazole Derivatives.
    Asif M; Almehmadi M; Alsaiari AA; Allahyani M
    Curr Org Synth; 2024; 21(7):858-888. PubMed ID: 37861007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic Approaches, Biological Activities, and Structure-Activity Relationship of Pyrazolines and Related Derivatives.
    Kumar R; Singh H; Mazumder A; Salahuddin ; Yadav RK
    Top Curr Chem (Cham); 2023 Apr; 381(3):12. PubMed ID: 37029841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase inhibitors and nanodelivery of diabetic therapeutics.
    Prior AM; Thapa M; Hua DH
    Mini Rev Med Chem; 2012 Apr; 12(4):326-36. PubMed ID: 22303947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines.
    Sever B; Altıntop MD; Demir Y; Yılmaz N; Akalın Çiftçi G; Beydemir Ş; Özdemir A
    Chem Biol Interact; 2021 Aug; 345():109576. PubMed ID: 34252406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of pyridazinone-substituted benzenesulphonylurea derivatives as anti-hyperglycaemic agents and inhibitors of aldose reductase - an enzyme embroiled in diabetic complications.
    Yaseen R; Pushpalatha H; Reddy GB; Ismael A; Ahmed A; Dheyaa A; Ovais S; Rathore P; Samim M; Akthar M; Sharma K; Shafi S; Singh S; Javed K
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1415-27. PubMed ID: 26879420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the inhibition profiles of pyrazolyl-thiazole derivatives against aldose reductase and α-glycosidase and molecular docking studies.
    Demir Y; Taslimi P; Koçyiğit ÜM; Akkuş M; Özaslan MS; Duran HE; Budak Y; Tüzün B; Gürdere MB; Ceylan M; Taysi S; Gülçin İ; Beydemir Ş
    Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000118. PubMed ID: 32761859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, hypoglycemic and aldose reductase inhibition activity of arylsulfonylspiro[fluorene-9,5'-imidazolidine]-2',4'-diones.
    Iqbal Z; Hameed S; Ali S; Tehseen Y; Shahid M; Iqbal J
    Eur J Med Chem; 2015 Jun; 98():127-38. PubMed ID: 26005026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
    Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
    Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of some new pyrazoline substituted benzenesulfonylurea/thiourea derivatives as anti-hyperglycaemic agents and aldose reductase inhibitors.
    Ovais S; Pushpalatha H; Reddy GB; Rathore P; Bashir R; Yaseen S; Dheyaa A; Yaseen R; Tanwar O; Akthar M; Samim M; Javed K
    Eur J Med Chem; 2014 Jun; 80():209-17. PubMed ID: 24780598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel aldose reductase inhibitors: a patent survey (2006--present).
    Chatzopoulou M; Alexiou P; Kotsampasakou E; Demopoulos VJ
    Expert Opin Ther Pat; 2012 Nov; 22(11):1303-23. PubMed ID: 22998509
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.